IRIDEX Corporation
IRIX
$1.03
$0.000.00%
NASDAQ
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index
Headlines
4/20/2026
-
Zacks Investment Research
4/17/2026
-
Zacks Investment Research
4/7/2026
-
TipRanks Financial Blog
4/7/2026
-
Globe Newswire
4/4/2026
-
Zolmax
4/1/2026
-
Zacks Investment Research
4/1/2026
-
Zacks Investment Research
4/1/2026
-
Zacks Investment Research
3/27/2026
-
The Fly
3/27/2026
-
Insider Monkey
3/26/2026
-
SeekingAlpha.com: All News
3/26/2026
-
SeekingAlpha.com: All News
3/26/2026
-
Seeking Alpha: Transcripts
3/26/2026
-
SeekingAlpha
3/26/2026
-
Nasdaq News: Markets
3/26/2026
-
Fool.com Headlines
3/26/2026
-
Ticker Report
3/26/2026
-
Seeking Alpha - Healthcare
3/26/2026
-
Globe Newswire
3/13/2026
-
TipRanks Financial Blog
3/12/2026
-
Globe Newswire
2/5/2026
-
TipRanks Financial Blog
2/5/2026
-
The Fly
2/2/2026
-
The Fly
2/2/2026
-
Globe Newswire
Income Statement
Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)
Balance Sheet
Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)
Cash Flow
Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)
Filings
Filing Date
Thursday, April 2, 2026
Period Date
Wednesday, December 31, 2025
Next Filing
Week of May 11 and 15 (est)
Price History
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return
52-week Low
52-week High
Valuation
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)
Dividends and Shares
Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
Phone Number
650 940 4700
Address
1212 Terra Bella Avenue
Mountain View, CA 94043
Mountain View, CA 94043
Country
Year Founded
Business Description
Sector
Industry
IRIDEX Corporation, an ophthalmic medical technology company, provides therapeutic based laser systems, delivery devices, and consumable instrumentation to treat sight-threatening eye diseases in...
more